Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.
ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...
Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...
Sept 24 (Reuters) - (This Sept.24 story has been refiled to remove a picture, with no changes to text) Investor group European Investors-VEB on Wednesday applied for a court inquiry into Philips ...
PITTSBURGH — A Pennsylvania federal court remanded a California woman’s negligence complaint over injuries allegedly caused by a recalled Philips CPAP device back to Los Angeles County Superior Court.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results